Search results
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters· 2 days ago, opens new tab multiple myeloma drug Blenrep nearly halved the risk of disease progression or death...
GSK, Pfizer Must Face 75,000 Zantac Cases, Delaware Judge Rules
Bloomberg· 3 days agoGSK Plc and Pfizer Inc. must face about 75,000 Zantac lawsuits filed in state court in Delaware...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Market Watch· 5 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 4 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year —...
GSK blood cancer drug nearly halves risk of death in late-stage trial
AOL· 2 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according ...
Will Zantac ruling make Delaware a mass torts magnet?
Reuters· 16 hours agoIf you are mass torts lawyer, you should be paying attention to a trend that has emerged in...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 hours agoIn April, Pfizer showed us positive phase 3 results from a trial with adults aged 18 to 59 years...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
Investing.com· 3 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Delaware judge lets more than 70,000 Zantac lawsuits go forward
KSL Salt Lake City· 3 days agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
The role of CAR-T cells in systemic lupus erythematosus
Clinical Trials Arena via Yahoo Finance· 5 hours agoTherefore, as there is not yet a definitive cure for the disease, currently available treatments...